Becton Dickinson (BDX): CEO reported a transaction in 17K shares
Thomas E Jr Polen, CEO at Becton Dickinson, reported a transaction of 17K shares.
- 17K
- Shares · @ $146.15
- Traded
- Jun 1, 2026
- Filed
- Jun 3, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 9, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 15, 2025, the Company filed a Current Report on Form 8-K that reported that Vitor Roque, who previously served as the Company’s Senior Vice President of Finance, Business Units and Corporate Financial Planning & Analysis, was appointed as the Company’s interim Chief Financial Officer, effective December 5, 2025.”
- Mar 17, 2026CongressDisclosed sale of BDX — reported range $15,001 - $50,000
- Mar 27, 2026CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
- Apr 2, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 6, 2026, Richard E. Byrd, Executive Vice President and President of the Interventional segment of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.”
- Apr 27, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
- Apr 28, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
- Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.4%
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 7, 2026Company filing · Form 8-K · ResultsReported its results
- May 15, 20265% stakeT. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 3.4%
- May 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- May 21, 2026CongressDisclosed sale of BDX — reported range $1,001 - $15,000
- May 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
- Jun 1, 2026InsiderCEO sold ~$405K of BDX shares in the open market
What came next
- Jun 10, 2026InsiderOfficer sold ~$167K of BDX shares in the open market
- Jun 24, 2026InsiderOfficer sold ~$160K of BDX shares in the open market
- Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: SureStep Intermittent Catheter Tray REF: INTP16 INTS14 INTS14C INTS16 INTS16C PEDINTS06 PEDINTS08 PEDINTS10 UDI code:…
- Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: *Bardex¿ I.C. Complete Care¿ Foley Catheter Tray REF: 300316A UDI codes: 00801741024344¿ 10801741024341 *Bardex¿ I.C.…
- Jun 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
- Jul 9, 2026FDARecall: BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTIO…
- Jul 10, 2026FDAFDA device clearance: Minnesota Four-Lumen Esophagogastric Tamponade Tube - 18 French (0092220); Blakemore Esophageal-Nasogastric Tube - 20 French (0092100); Blakemore Esophageal-Na…
- Jul 19, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 19, 2026, Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.”
- Jul 27, 2026InsiderOfficer sold ~$12K of BDX shares in the open market
- Jul 30, 2026FDARecall: BD Needle Kit for Powered Driver 15mm x 15Ga, REF: D015151NK, BD Needle Kit for Powered Driver 25mm x 15Ga, REF: D015251NK, BD Needle Kit for Powered Driver 35…
- Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 6, 20265% stakeFirst Eagle Investment Management, LLC reported a passive stake (13G) of 5.1%
- Aug 7, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.4%
- Aug 10, 2026FDARecall: Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605150; Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605200; Power-Trialysis Short…
- Aug 10, 2026FDARecall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150; DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625200; DuoGlide Short-Term Straight Dialys…
- Aug 11, 2026FDARecall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximeter cable is intended for use as an adjunct moni…
- Aug 11, 2026InsiderOfficer sold ~$441K of BDX shares in the open market
- Aug 13, 2026FDARecall: BD Phoenix Panel NMIC-306. Catalog Number: 449292.
- Aug 13, 2026FDARecall: BD Phoenix Panel NMIC-312. Catalog Number: 449082.
- Aug 13, 2026InsiderCEO sold ~$768K of BDX shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Becton Dickinson
For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.
Other recent filings by Thomas E Jr Polen, Chairman, CEO and President
- SEC Form 4 at Becton Dickinson (BDX)Nov 9, 2026
- SEC Form 4 at Becton Dickinson (BDX)Aug 14, 2026
- SEC Form 4 at Becton Dickinson (BDX)Jun 3, 2026
The full history of Thomas E Jr Polen, Chairman, CEO and President is on the profile page.
How this filing works
Explore the data
Common questions
Which Becton Dickinson (BDX) insider traded, and how much?
Thomas E Jr Polen, CEO at Becton Dickinson, reported a transaction of 17K shares. At $146.15.
When did it happen, and when was it made public?
Traded: Jun 1, 2026. Filed: Jun 3, 2026. That is 2 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Becton Dickinson recently?
For Becton Dickinson, OQRO holds 8 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the BDX page.
Does this mean BDX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Becton Dickinson
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 4Oct 27, 2026
- SEC Form 144Oct 26, 2026
Everything OQRO holds on this company is on its BDX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
